Sermo, the largest global healthcare polling company and social platform for physicians, leveraged its capabilities to publish results of a COVID-19 study with more than 6,200 physicians in 30 countries. The study was completed in three days.
Hydroxychloroquine war rated the most effective therapy by those who used the medication.
BUSINESSWIRE SUMMARY
Treatments & Efficacy
- The three most commonly prescribed treatments amongst COVID-19 treaters are 56% analgesics, 41% Azithromycin, and 33% Hydroxychloroquine
- Hydroxychloroquine usage amongst COVID-19 treaters is 72% in Spain, 49% in Italy, 41% in Brazil, 39% in Mexico, 28% in France, 23% in the U.S., 17% in Germany, 16% in Canada, 13% in the UK, and 7% in Japan.
- Hydroxychloroquine was overall chosen as the most effective therapy amongst COVID-19 treaters from a list of 15 options. (37% of COVID-19 treaters)
-
- 75% in Spain, 53% in Italy, 44% in China, 43% in Brazil, 29% in France, 23% in the U.S., and 13% in the UK.
- The two most common treatment regimens for Hydroxychloroquine were:
-
-
- (38%) 400mg twice daily on day one; 400 mg daily for five days
- (26%) 400mg twice daily on day one; 200mg twice daily for four days
-
-
- Outside the U.S., Hydroxychloroquine was equally used for diagnosed patients with mild to severe symptoms whereas in the U.S. it was most commonly used for high risk diagnosed patients.
- Globally, 19% of physicians prescribed or have seen Hydroxychloroquine prophylactically used for high-risk patients, and 8% for low-risk patients.
-
A small controlled study in China found hydroxychloroquine to be ineffective.
-
Christian Gold Company Defies Industry’s Retirement Fearmongering Through Prayer and Biblical Hope
Dr. Colyer discusses the treatment with Fox News host Laura Ingraham on her nightly show:
wpDiscuz
